Background. Informed decision-making requires the presentation of all possible courses of action; however, it is unclear what proportion of Stage 5 chronic kidney disease (CKD) patients are routinely informed of all their treatment options. The aim of this study was to determine the effect of patient and unit characteristics on the type and timing of information provided. Methods. A prospective national multi-centre study of information was given to incident pre-emptive transplant, dialysis and conservatively managed patients in Australian renal units, over a 3-month period. Results. Sixty-six of 73 renal units participated in the study. Seven hundred and twenty-one incident CKD Stage 5 patients including 102 who chose not to dialyse were identified. Of these, 603 (84%) were presented with information about their options prior to commencing treatment. Three quarters (n = 543) were presented with home dialysis, one-third (n = 230) pre-emptive transplantation and 65% (n = 470) were informed about conservative care as an option. Patients were more likely to receive information prior to commencing treatment if they were known to a nephrologist for more than 3 months (OR 7.29, 95% CI 3.86-13.79) or were treated in small units with <100 dialysis patients (OR 2.40, 95% CI 1.26-4.60). The mean estimated glomerular filtration rate at the time information was first presented was 13.3 mL/min/1.73 m 2 (95% CI 12.7-13.8) and mean serum creatinine was 449 μmol/L (95% CI 431-467). Conclusions. Most Australian patients were informed of their treatment options prior to starting treatment, albeit in late stage CKD. Earlier education and support for informed decision-making may help optimize the uptake of pre-emptive transplantation and home dialysis therapies.
Introduction
Treatment options for patients with Stage 5 chronic kidney disease (CKD) include pre-emptive transplantation, peritoneal dialysis (PD), haemodialysis (HD) and supportive non-dialytic management, also known as conservative care. Of these options, centre-based HD is the most widely used worldwide despite being associated with poorer survival and lower patient-reported quality of life than pre-emptive transplantation or home dialysis [1, 2] . When patients are informed of all their treatment options and supported to make a choice between therapies, many have displayed preferences for transplantation and PD in particular [3] [4] [5] [6] .
Informed decision-making is defined as 'a reasoned choice being made by a reasonable individual using relevant information about the advantages and disadvantages of all the possible courses of action in accord with the individual's beliefs' [7] . International guidelines support the notion of informed decision-making via recommendations that patients with CKD and their families are fully informed about their options, 6-12 months prior to the predicted onset of end-stage disease or during Stage 4 or Stage 5 CKD when the patient's estimated glomerular filtration rate (eGFR) reaches <30 mL/min/1.73 m 2 [8] [9] [10] [11] [12] . However, up to 30% of patients start renal replacement therapy without having had any treatment options presented [13] , and not all patients who may be eligible for pre-emptive transplantation or home dialysis are made aware of these options.
Adequate and timely discussion of treatment options provides patients and nephrologists with time to approach and screen living donors, time to arrange training for patients who choose a home dialysis modality and time to establish a native fistula or peritoneal catheter for those treated with dialysis [12] [13] [14] . PINOT (Patient INformation about Options for Treatment) was designed as a prospective national study of information provided by renal units to all incident pre-emptive transplant, dialysis and conservatively managed patients identified during a 3-month period. The aims of the study were to determine the proportion of incident patients who received information about their options prior to commencing treatment, determine the patient's CKD stage when information about treatment options was first given and examine the associations between patient and unit characteristics on the timing of information provision and initial treatment modality.
Materials and methods
All Australian renal units and private nephrology practices that contribute to the Australia and New Zealand Dialysis and Transplant Association registry (ANZDATA, www.anzdata.org.au) were invited to participate in the study. Nephrologists and CKD coordinators completed a web-based questionnaire regarding the information about treatment options provided by their renal unit to each incident CKD Stage 5 patient presenting between 1 July and 30 September 2009. Staff sourced data from renal unit databases, physician letters detailing treatment discussions and patient charts. Patients with acute kidney injury and those returning to dialysis from a failed transplant were excluded from the study. Patients were defined as 'conservative' if a decision had been made not to dialyse, their eGFR was <15 mL/min/1.73 m 2 on consecutive measurements, and they did not commence dialysis within the 3-month study timeframe. Detailed methods have been reported elsewhere [15] .
Source data verification and completion of the questionnaires by a second clinician were undertaken for 20% of the total sample. Observer agreement between the two clinicians was reported using a kappa statistic. The study was approved by the University of Sydney Human Research Ethics Committee (protocol #11261) and relevant hospital ethics boards.
Statistical methods
Analyses were performed using SAS version 9.2 statistical software (www.sas.com). Logistic regression was performed to estimate the effects of patient and unit characteristics on the likelihood of provision of information prior to treatment, type of dialysis access and initial treatment commenced. Odds ratio estimates with 95% confidence intervals (CI) were reported for characteristics that showed a statistically significant as- sociation. A one-sample binomial test was performed to assess the proportion of patients not receiving information prior to treatment from a previously reported value of 30% [13] .
Results
Sixty-six of 73 Australian renal units participated in the study representing all major renal units, and 95% of all patients receiving renal replacement therapy. Two paediatric centres and five private nephrology practices which were not different to others in the study declined or did not respond to our invitation to participate. Throughout the 3-month study period, 721 incident Stage 5 CKD patients were identified and included in the analysis (Table 1, Figure 1) , including 5 who died from other causes before starting planned treatment. The median age of the group was 67 years, slightly higher than the Australian median of 63 years reflecting the inclusion of patients managed with conservative care. Most patients, 60%, were known to a nephrologist for more than 1 year (Table 1) . In 603 of 721 (84%) CKD Stage 5 patients, information about treatment options was provided prior to commencing treatment. Of the remaining 118 patients (16%), 88 did not receive information prior to commencing treatment, and these data were unknown for 30 (4%). Observer agreement was 89% with a Kappa statistic of 0.8947, demonstrating almost perfect strength of agreement [16] . Compared to previously reported values of 30% [13] , we found a significantly lower proportion of patients not receiving information prior to treatment commencement (95% CI 13.8-19.4, P < 0.001). Considering dialysis patients only (n = 588), 17.5% (95% CI 14.5-20.8) did not receive information about treatment options prior to starting dialysis which was also significantly better than previously reported estimates (P < 0.001) [13] . Of the 88 patients not receiving information prior to commencing treatment, 42 were known to a nephrologist for <3 months. In the remaining 46 patients, 7 refused information, 6 were not referred for education by their nephrologist, 4 were not candidates for dialysis, 3 transferred to another renal unit, 2 lived remotely from a renal unit, 2 had dementia and in 22 the reason was not stated. Increasing time known to a nephrologist and treatment at a small renal unit with <100 dialysis patients were associated with a higher likelihood of receiving information prior to commencing treatment ( Table 2) .
Timing of information
Information about treatment options was initially received in Stage 5 CKD for 65% of patients, Stage 4 for 32%, Stage 3 for 2% and Stage 2 CKD for 1%. When information about treatment options was first presented, the mean eGFR was 13.3 mL/min/1.73 m 2 (95% CI 12.7-13.8, n = 641 patients) and the mean serum creatinine was 449 μmol/L (95% CI 431-467, n = 647 patients). (In six paediatric patients, eGFR was unable to be calculated because data on height were not provided.) The median time between initial information provision and first treatment was 6 months (range: 2 days-96 months). (32%) and conservative care to 470 (65%). The reasons why specific treatment options were not presented to patients are listed in Table 3 . Information was most often provided as part of a discussion in a nephrology or specialist nurse consultation with the provision of printed materials (Figure 2) . The proportion of patients receiving information prior to commencing treatment in each initial modality is shown in Table 4 .
Type of treatment options presented

Dialysis access
There were 588 new patients commencing dialysis during the study period. Of these, 317 (54%) used a permanent access for their first dialysis treatment (PD catheter = 133, fistula/graft = 177 or tunnelled permanent catheter = 7). Multivariate analysis showed that patients known to a nephrologist for longer than 3 months were significantly less likely to have temporary vascular access (OR 0.12, 95% CI 0.07-0.22, P < 0.001). Patient age, gender, language spoken at home, type of health insurance and size of the renal unit were not predictors of temporary dialysis access.
Pre-emptive transplantation and home dialysis
A significantly higher proportion of patients who received a pre-emptive transplant had private health insurance compared to those starting centre-based HD (40 vs 21%, OR 2.73, 95% CI 1.11-6.71, P = 0.019). Similarly a smaller proportion were known to a nephrologist for <3 months (6 vs 29%, OR 0.13, 95% CI 0.02-0.97, P = 0.005) and first received information about treatment options in 'late stage', i.e. Stage 5 CKD (48 vs 73%, OR 0.39, 95% CI 0.17-0.91, P = 0.011) (Figure 3 ). The five patients who died before starting planned treatment were excluded.
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A home-based dialysis therapy was commenced in 146 of 721 (20%) of new patients. The proportion of patients known to a nephrologist for <3 months was significantly lower in those commencing home dialysis compared to those starting centre-based HD (8 vs 29%, OR 0.24, 95% CI 0.13-0.46, P < 0.001). Likewise, patients starting home dialysis were more likely to have a caregiver with them at time of information presentation (80 vs 59%, OR 2.52, 95% CI 1.59-4.01, P < 0.001) ( Figure 3A) . Separate analysis revealed that home patients were significantly less likely to commence dialysis with a temporary access (1 vs 61%, OR 0.009, 95% CI 0.002-0.037, P < 0.001). There was no significant difference in the proportion of home dialysis patients who received information about their treatment options in CKD Stage 5 compared with centre-based HD (home dialysis 66% vs centre-based HD 73%). Mean eGFR at time of first presentation of treatment options was 13.4, 13.9 and 13.5 mL/min/1.73 m 2 for home HD, PD and centre HD patients, respectively.
Planned modality switches
Of the 443 patients who initially commenced centre-based HD, 111 (18%) were planned to move to PD, home HD and living-donor transplantation within the next 6 months (Table 5 ). Seventy patients who commenced dialysis initially were to be placed on the deceased-donor transplant waiting list.
Discussion
The majority of patients (84%) received information about their treatment options prior to commencing treatment, albeit in late stage CKD when their eGFR was <15 mL/min/ 1.73 m 2 . Patients known to a nephrologist for more than 3 months and those from smaller renal units were most likely to receive information prior to commencing treatment. Patients who were pre-emptively transplanted were more likely to have private health insurance and receive information about their treatment options at an earlier stage of disease, compared to centre-based HD patients. Patients commencing home dialysis were referred earlier to a nephrologist, received information with their caregivers present and started dialysis with a permanent access more often than centre-based HD patients. Despite the number of patients receiving information about treatment options being higher than previously reported, there is still room for improvement. Approximately half of the patients not receiving prior information (n = 46) were known to a nephrologist for more than 3 months. Although the reasons for this were unreported, a possible explanation may be that the rate of progression of kidney disease in these patients was faster than predicted or that these patients became symptomatic and needed dialysis earlier than their biochemistry anticipated. In a small number of patients unsuitable for dialysis, the discussion about treatment options (including conservative care) was not raised.
One Canadian study reported that 66% of new patients commencing dialysis received information about their treatment options before starting treatment [17] , whereas a Spanish multi-centre study reported that only 34% of dialysis patients were educated about treatment options prior to commencing dialysis [18] . Consistent with our study, late referral and limited pre-dialysis education were shown to influence the initial modality in favour of centrebased HD therapy [19] .
Recommendations from the UK National Framework for Renal Services [8] suggest that information be provided 12 months prior to the anticipated need for renal replacement therapy, which gives patients and their families time to consider and plan for their future chosen treatment. In order to prevent patients with rapidly progressive disease from missing discussions about treatment options, our study suggests that education is probably best commenced in Stage 4 rather than Stage 5 CKD.
Presentation of a complete range of treatment options, i.e. inclusive of pre-emptive transplant, home dialysis and conservative care, may be helpful for patients and their families to make decisions about future treatment. Many of the patients in this study who were not presented with pre-emptive transplantation were considered too old or medically unsuitable. In a few eligible patients, however, the opportunity to prepare recipients and donors was lost when patients presented acutely or had low levels of literacy. The provision of information alone is not enough to ensure patients make an informed choice. Patients need to be encouraged to reason with the information and evaluate the benefits and risks of each treatment in terms of their own values [20] .
In contrast to other work that found only 25-30% of patients were presented with PD as a treatment option [13, 21] , we found that 72% of incident patients in Australia were presented with a PD treatment alternative by their renal unit. Our results were similar to Finkelstein and colleagues who reported that 65% of Canadian and US CKD Stage 5 patients were aware of PD as a treatment option [22] . Our study showed that only 53% of incident patients were presented with home HD as a treatment option. Medical or surgical contraindications were partly responsible for this, as were unsuitable living conditions, low literacy, no social supports, psycho-social contraindications and patient or family refusal.
Data from other studies indicate that patients prefer to remain on their initial modality [23] which may determine their eventual modality at 1 year. A treatment switch requires coordination between surgical, medical and nursing departments and maintaining the status quo (i.e. remaining on the current therapy) in situations where there are no immediate problems may be preferred by both patients and clinicians. Follow-up of the PINOT cohort could determine how many of the 111 patients planned to switch to a home therapy or living-donor transplantation actually did switch within the subsequent 6-month time frame.
Our study showed that information about treatment options was most commonly delivered in the renal unit by a nephrologist or nurse with the use of printed materials. The most effective way to present information to CKD patients is poorly understood; however, patients and their families have reported benefits of education from their peers [24] . Social cognitive theory suggests that learning is expedited when individuals are able to observe the behaviours of others who are similar to them [25] . A patient with CKD may be more willing to learn from another patient whose experiences resonate with that patient's unique personal history. Formal peer education is a component of many CKD education programmes; however, it appeared to be underutilized in Australian units. This topic deserves further research as some claim patient narratives may bias treatment decision-making [26] .
Preliminary results from a UK study on patient preferences for pre-dialysis education indicated that patients wanted information delivered in a hospital setting using computer-aided technology rather than via printed text (Sedgewick JM: Conjoint analysis-a novel approach to identifying patient preferences for pre-dialysis education (Abstract). Renal Society of Australasia Journal. 2:19, 2006) . Patients also preferred education sessions on an individual rather than group basis that were conducted once a month and lasted no more than 1 h. Published randomized controlled trials in this field have only evaluated a single session of education in their intervention thereby making assessment of the effectiveness of multiple education sessions difficult [27] [28] [29] . The involvement of the patient's caregiver in the presentation of treatment options may be also critical to the success of starting renal replacement therapy at home [30] , and perhaps renal units should formally encourage their participation.
Our study recruited 66 centres from a total of 73 nationally, which represented~95% of new dialysis and transplant patients based on registry numbers over a preceding 3-month period. High participation rates meant that the study population was reflective of the Australian CKD population and likely generalizable to Stage 5 patients where options for treatment such as pre-emptive transplantation and home dialysis are available. We eliminated patient recall bias about the type and timing of information received by surveying renal clinicians and retrieving data from nephrologist letters as well as CKD and pre-dialysis databases. This study was not able to assess how the information was used and how treatment options were discussed to determine how patients 1272 R.L. Morton et al.
were making their decisions. Data on the time interval between provision of information and commencement of treatment were also limited to a small subsample of the PINOT cohort and may not be generalizable to a broader CKD Stage 5 population. Further research is required to address the barriers to timely education, especially the effect of unit size and patient's health insurance status. Research is also required to evaluate the content and delivery of the information about treatment options-i.e. 'effective education' to determine whether verbal consultations, printed materials, DVDs, unit tours or websites are comprehensible and meet the needs of new patients. In a recent UK survey of printed educational materials given to CKD patients, most were 'very hard to understand' on the Flesch readability scale, which made the information inaccessible for patients and inadequate to facilitate informed decision-making [31] .
Conclusion
Our large multi-centre cohort study confirms that the majority of Australian patients received information about treatment options prior to starting treatment albeit in late stage CKD. Earlier education and support for informed decision-making may help to optimize the uptake of preemptive transplantation and home dialysis therapies.
